
BELLUS Health BLU
Annual report 2022
added 12-28-2024
BELLUS Health P/CF Ratio 2011-2026 | BLU
Annual P/CF Ratio BELLUS Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -8.62 | -7.58 | -19.8 | - | -5.09 | -5.73 | -17.6 | -15 | -6.49 | -4.16 | -1.86 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.86 | -19.8 | -9.19 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Aclaris Therapeutics
ACRS
|
-7.59 | $ 2.69 | 0.19 % | $ 208 M | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 208.25 | -2.36 % | $ 5 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.42 | 6.54 % | $ 8.23 B | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 4.35 | -7.64 % | $ 9.47 B | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.91 | -2.31 % | $ 487 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 98.56 | -1.52 % | $ 27.2 B | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.13 | $ 27.72 | 1.43 % | $ 1.34 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 | $ 11.49 | -2.21 % | $ 743 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Axon Enterprise
AXON
|
97.5 | $ 611.74 | -1.48 % | $ 46.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-8.14 | $ 2.71 | -4.24 % | $ 17 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
AstraZeneca PLC
AZN
|
13.6 | $ 94.15 | -1.06 % | $ 96.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.323 | - | -9.72 % | $ 5.89 M | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | ||
|
BioVie
BIVI
|
-0.128 | $ 1.3 | -4.07 % | $ 1.92 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 9.29 | -0.05 % | $ 1.51 B | ||
|
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | ||
|
Biogen
BIIB
|
6.73 | $ 185.27 | -0.88 % | $ 27 B | ||
|
Abeona Therapeutics
ABEO
|
-4.04 | $ 5.1 | -2.39 % | $ 109 M | ||
|
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M | ||
|
ADiTx Therapeutics
ADTX
|
-0.00353 | $ 0.84 | -0.24 % | $ 11.1 K | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M |